Dinaciclib inhibits the stemness of two subtypes of human breast cancer cells by targeting the FoxM1 and Hedgehog signaling pathway
Ai-Ni Tsao(National Yang Ming Chiao Tung University), Ta‐Chung Chao(National Yang Ming Chiao Tung University)
Cited by 20